These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26394538)

  • 1. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
    Treloar C; Rance J; Yates K; Mao L
    Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations.
    Treloar C; Newland J; Maher L
    Harm Reduct J; 2015 Mar; 12():5. PubMed ID: 25884357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
    Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
    Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
    Wilson H; Brener L; Mao L; Treloar C
    Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
    Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
    Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist experiences of providing needle and syringe programmes in Ireland.
    McVeigh J; Hearne E; Bates G; Van Hout MC
    Res Social Adm Pharm; 2017; 13(4):767-777. PubMed ID: 27568822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
    Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
    Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
    Muncan B; Walters SM; Ezell J; Ompad DC
    Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
    Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
    Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
    Sawangjit R; Khan TM; Chaiyakunapruk N
    Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
    Deryabina A; El-Sadr WM
    Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid users and the unique challenge they pose to needle and syringe program workers.
    Dunn M; McKay FH; Iversen J
    Drug Alcohol Rev; 2014 Jan; 33(1):71-7. PubMed ID: 24400704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need.
    Treloar C; Mao L; Wilson H
    Harm Reduct J; 2016 May; 13(1):18. PubMed ID: 27246345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.
    Ibragimov U; Cooper HL; Haardörfer R; Dunkle KL; Zule WA; Wong FY
    Harm Reduct J; 2017 Sep; 14(1):64. PubMed ID: 28915888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
    Brener L; Spooner C; Treloar C
    Int J Drug Policy; 2010 May; 21(3):160-4. PubMed ID: 19427187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
    O'Keefe D; Aitken C; Scott N; Dietze P
    Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
    Newland J; Newman C; Treloar C
    Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
    Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community health workers: a bridge to healthcare for people who inject drugs.
    Morgan K; Lee J; Sebar B
    Int J Drug Policy; 2015 Apr; 26(4):380-7. PubMed ID: 25477284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
    White B; Haber PS; Day CA
    Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.